Abstract
Objective: Statins have been shown to reduce the cardiac remodeling independent of their well-known lipid lowering effect. Considering the importance of transforming growth factor-beta1 (TGF-β1) overproduction in heart failure, the effect of atorvastatin on TGF-β1 expression and p44/42 mitogen-activated protein kinases (p44/42 MAPK) signal transduction passway in cardiac fibroblasts was examined. Design andmethods: The cardiac fibroblasts of neonatal rat were culturedby trypsinogen anddifferent speed adherence. The level of TGFβ1 in conditioned medium was measured by EIA. Intracellular TGF-β1, p44/42 MAPK and phospho-p44/42 MAPK levels were evaluated by Western blot, and the expression of TGF-β1 mRNA was detected using RT-PCR. Results: The cardiac fibroblasts, treated with aldosterone at 1×10−7mol/L, significantly up-regulated TGF-β1 mRNA expression (P<0.01), as well as TGF-β1 synthesis (P<0.01) and release (P<0.01). Atorvastatin (1×10−6, 10−5, 10−4mol/L) dose-dependently blocked TGF-β1 mRNA expression (P<0.01, respectively), as well as TGF-β1 synthesis (P<0.01, respectively) and release (P=0.113, P<0.01, P<0.01, respectively). In contrast, atorvastatin-induced inhibitory effects were reversed in the presence of mevalonate. Similarly, phospho-p44/42 MAPK was significantly up-regulated by aldosterone (P<0.01). The increased level of phospho-p44/42 MAPK was reduced when the cells were pretreated with atorvastatin (P<0.01). Our data also showed the recovery of phospho-p44/42 MAPK expression in the presence of mevalonate (P<0.01). Pre-incubation with PD 98059, an antagonist for p44/42 MAPK, abolished aldosterone-induced TGF-β1 secretion (P<0.01). Conclusion: Atorvastatin down-regulated TGF-β1 expression inducedbyaldosterone in aprocess specifically related tomevalonate and p44/42 MAPK pathway in cultured neonatal rat cardiac fibroblasts. Thus, itwas indicated that atorvastatinmight exert therapeutic effects bya new possible mechanism in patients with heart failure.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have